SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005150-04-000086
Filing Date
2004-01-23
Accepted
2004-01-23 15:41:46
Documents
3
Period of Report
2004-01-22
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.txt 8-K 3806
3 ex99-1.txt EX-99.1 5458
4 ex99-2.txt EX-99.2 6542
  Complete submission text file 0001005150-04-000086.txt   17655
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15070 | Film No.: 04540701
SIC: 2834 Pharmaceutical Preparations